Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Smoking induces long-lasting effects through a monoamine-oxidase epigenetic regulation.
Non-lesional white matter changes in pediatric multiple sclerosis and monophasic demyelinating disorders.
Update on PML and PML-IRIS Occurring in Multiple Sclerosis Patients Treated With Natalizumab.
[Sexuality of men with neurologic disorders].
Cbl-b-deficient mice express alterations in trafficking-related molecules but retain sensitivity to the multiple sclerosis therapeutic agent, FTY720.
Inhibition of glial proliferation, promotion of axonal growth and myelin production by synthetic glycolipid: A new approach for spinal cord injury treatment.
A prospective observational safety study on MF59(®) adjuvanted cell culture-derived vaccine, Celtura(®) during the A/H1N1 (2009) influenza pandemic.
The autonomic balance predicts cardiac responses after the first dose of fingolimod.
Plasma chemerin levels in patients with multiple sclerosis.
[Chronic cerebrospinal venous insufficiency--pathophysiology and treament].
The spectrum of MOG autoantibody-associated demyelinating diseases.
Suppression of Experimental Autoimmune Optic Neuritis by the Novel Agent Fingolimod.
[Symptoms of circadian desynchronization in patients with multiple sclerosis.]
Exome sequencing in single cells from the cerebrospinal fluid in multiple sclerosis.
The effect of the neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: a pilot study.
Neurorestorative effect of FTY720 in a rat model of Alzheimer's disease: Comparison with Memantine.
DMDs Are an Essential Issue But Are They the Only Issue in MS Treatment?
Added benefit of fampridine is not proven
Cognitive impairment in neuro-Behcet's disease and multiple sclerosis: a comparative study.
Network analysis of transcriptional regulation in response to intramuscular interferon-β-1a multiple sclerosis treatment.
Sleep-disordered breathing in multiple sclerosis.
Microparticle Platform
[Epstein-Barr virus in the pathogenesis of multiple sclerosis (a review).]
Strategies for myelin regeneration: lessons learned from development.
Spatial and temporal characteristics of gait as outcome measures in multiple sclerosis (EDSS 0 to 6.5).
Pages
« first
‹ previous
…
153
154
155
156
157
158
159
160
161
…
next ›
last »